Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The risk of second malignancies following prostate cancer radiotherapy in the era of conformal radiotherapy: a statement of the Prostate Cancer Working Group of the German Society of Radiation Oncology (DEGRO).
Zamboglou C, Aebersold DM, Albrecht C, Boehmer D, Ganswindt U, Schmidt-Hegemann NS, Hoecht S, Hölscher T, Koerber SA, Mueller AC, Niehoff P, Peeken JC, Pinkawa M, Polat B, Spohn SKB, Wolf F, Zips D, Wiegel T. Zamboglou C, et al. Strahlenther Onkol. 2024 Aug 28. doi: 10.1007/s00066-024-02288-6. Online ahead of print. Strahlenther Onkol. 2024. PMID: 39196366
PSMA-PET based radiotherapy: a review of initial experiences, survey on current practice and future perspectives.
Zschaeck S, Lohaus F, Beck M, Habl G, Kroeze S, Zamboglou C, Koerber SA, Debus J, Hölscher T, Wust P, Ganswindt U, Baur ADJ, Zöphel K, Cihoric N, Guckenberger M, Combs SE, Grosu AL, Ghadjar P, Belka C. Zschaeck S, et al. Among authors: zamboglou c. Radiat Oncol. 2018 May 11;13(1):90. doi: 10.1186/s13014-018-1047-5. Radiat Oncol. 2018. PMID: 29751842 Free PMC article. Review.
Outcome after PSMA PET/CT based salvage radiotherapy in patients with biochemical recurrence after radical prostatectomy: a bi-institutional retrospective analysis.
Schmidt-Hegemann NS, Stief C, Kim TH, Eze C, Kirste S, Strouthos I, Li M, Schultze-Seemann W, Ilhan H, Fendler WP, Bartenstein P, Grosu AL, Ganswindt U, Belka C, Meyer PT, Zamboglou C. Schmidt-Hegemann NS, et al. Among authors: zamboglou c. J Nucl Med. 2019 Feb 1;60(2):227-233. doi: 10.2967/jnumed.118.212563. Epub 2018 Jul 12. J Nucl Med. 2019. PMID: 30002108 Free PMC article.
Impact of 68Ga-PSMA PET/CT on the Radiotherapeutic Approach to Prostate Cancer in Comparison to CT: A Retrospective Analysis.
Schmidt-Hegemann NS, Eze C, Li M, Rogowski P, Schaefer C, Stief C, Buchner A, Zamboglou C, Fendler WP, Ganswindt U, Cyran C, Bartenstein P, Belka C, Ilhan H. Schmidt-Hegemann NS, et al. Among authors: zamboglou c. J Nucl Med. 2019 Jul;60(7):963-970. doi: 10.2967/jnumed.118.220855. Epub 2018 Dec 14. J Nucl Med. 2019. PMID: 30552203 Free PMC article.
Intraindividual comparison between 68Ga-PSMA-PET/CT and mpMRI for intraprostatic tumor delineation in patients with primary prostate cancer: a retrospective analysis in 101 patients.
Spohn S, Jaegle C, Fassbender TF, Sprave T, Gkika E, Nicolay NH, Bock M, Ruf J, Benndorf M, Gratzke C, Grosu AL, Zamboglou C. Spohn S, et al. Among authors: zamboglou c. Eur J Nucl Med Mol Imaging. 2020 Nov;47(12):2796-2803. doi: 10.1007/s00259-020-04827-6. Epub 2020 Apr 28. Eur J Nucl Med Mol Imaging. 2020. PMID: 32342192 Free PMC article.
128 results